Clalit Health Services was selected as a partner in the PANDAI research project, an international consortium focused on using artificial intelligence to predict and manage pandemics. The project operates with a budget of €8 million.

Horizon Europe is the primary donor for the PANDAI project. Various research organizations are involved, including those from the United Kingdom, Spain, Denmark, Luxembourg, and Bangladesh. The World Health Organization and the University of Oxford are also partners in the initiative.

Clalit Health Services operates community clinics and hospitals that utilize advanced electronic medical records. The organization led Israel's response to COVID-19 in 2020. During that period, Clalit Health Services published large-scale studies concerning the effectiveness and safety of COVID-19 vaccines.

"In the post-COVID era, we must be prepared for the possibility of another major global health event," said Prof. Eytan Wirtheim, CEO of Clalit Health Services. "At a time when international collaboration faces increasing challenges, this achievement demonstrates that the knowledge, research, and innovation developed by Clalit and the Israeli healthcare system continue to play an important role in the global effort to shape the future of medicine."

"This is both a great honor and a major responsibility," said Prof. Doron Netzer, head of medicine at Clalit's Community Division. "One of the world's leading research frameworks has recognized Clalit's research capabilities, expertise, and experience in operating a healthcare system during periods of uncertainty and global pandemics. The COVID-19 pandemic demonstrated that Israel's community healthcare system, with Clalit at its forefront, serves as a critical first line of defense against emerging health threats."

No independent assessment of Clalit Health Services’s claims was available.